FMR1 and fragile X syndrome: This may imply that the difference between FXS hESCs and iPSCs in the timing of epigenetic silencing of FMR1 may be crucial for investigating the neural phenotype of the disease, since FXS iPSCs neurons are likely to present a more drastic phenotype than their FXS hESCs counterparts.